[HTML][HTML] Nicotine induces resistance to erlotinib therapy in non-small-cell lung cancer cells treated with serum from human patients
T Imabayashi, J Uchino, H Osoreda, K Tanimura… - Cancers, 2019 - mdpi.com
Previously, we reported that nicotine reduces erlotinib sensitivity in a xenograft model of
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
[HTML][HTML] Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients
T Imabayashi, J Uchino, H Osoreda, K Tanimura… - Cancers, 2019 - ncbi.nlm.nih.gov
Previously, we reported that nicotine reduces erlotinib sensitivity in a xenograft model of
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
[PDF][PDF] Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients
T Imabayashi, J Uchino, H Osoreda, K Tanimura… - pdfs.semanticscholar.org
Previously, we reported that nicotine reduces erlotinib sensitivity in a xenograft model of
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients.
T Imabayashi, J Uchino, H Osoreda, K Tanimura… - …, 2019 - search.ebscohost.com
Previously, we reported that nicotine reduces erlotinib sensitivity in a xenograft model of
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients.
T Imabayashi, J Uchino, H Osoreda, K Tanimura… - Cancers, 2019 - europepmc.org
Previously, we reported that nicotine reduces erlotinib sensitivity in a xenograft model of
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients
T Imabayashi, J Uchino, H Osoreda, K Tanimura… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Previously, we reported that nicotine reduces erlotinib sensitivity in a xenograft model of
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients
T Imabayashi, J Uchino, H Osoreda, K Tanimura… - …, 2019 - search.proquest.com
Previously, we reported that nicotine reduces erlotinib sensitivity in a xenograft model of
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients.
T Imabayashi, J Uchino, H Osoreda, K Tanimura… - Cancers, 2019 - europepmc.org
Previously, we reported that nicotine reduces erlotinib sensitivity in a xenograft model of
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …
PC9, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-sensitive non …